PBM

Propel Bio Management Portfolio holdings

AUM $82.4M
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$172M
AUM Growth
+$51.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$25.7M
2
+$11.1M
3
+$5.75M
4
APLT icon
Applied Therapeutics
APLT
+$5.01M
5
PHAT icon
Phathom Pharmaceuticals
PHAT
+$4.53M

Top Sells

1
+$21.9M
2
+$5.87M
3
+$2.13M
4
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
+$2.13M
5
SPSB icon
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$1.36M

Sector Composition

1 Healthcare 78.83%
2 Technology 1.46%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$41.6M 24.19%
6,111,906
+736,924
2
$28M 16.29%
1,492,581
+1,372,360
3
$16.6M 9.65%
2,087,139
4
$11.5M 6.69%
43,032
+13,000
5
$11.1M 6.49%
+2,453,092
6
$9.24M 5.38%
869,927
+426,880
7
$8.28M 4.82%
327,752
+227,700
8
$7.08M 4.12%
750,000
9
$4.56M 2.65%
178,500
10
$4.47M 2.6%
270,664
11
$4.34M 2.52%
594,174
12
$4.09M 2.38%
1,492,792
13
$2.77M 1.61%
130,000
14
$2.5M 1.46%
290,781
15
$2.27M 1.32%
56,359
16
$2.07M 1.21%
22,400
17
$1.98M 1.15%
+83,259
18
$1.76M 1.02%
70,000
19
$1.63M 0.95%
180,100
20
$1.47M 0.86%
147,033
21
$1.1M 0.64%
195,000
22
$897K 0.52%
+260,000
23
$744K 0.43%
17,833
24
$732K 0.43%
146,381
25
$485K 0.28%
4,456
1
2